HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A clinicopathologic study of orbital and adnexal non-Hodgkin's lymphoma.

Abstract
An analysis of non-Hodgkin's lymphoma involving the orbital structures was performed at the University of Iowa between 1937 and 1975. Sixteen cases of primary orbital lymphoma were diagnosed. Histopathologic reclassification according to the Rappaport scheme and the clinical course of each histologic sub-category was described. There were 5 patients with reactive hyperplasia, 2 patients with well-differentiated lymphoid proliferation with Dutcher bodies which were also felt to be reactive, 3 patients with diffuse poorly differentiated lymphocytic lymphoma, 4 patients with nodular poorly differentiated lymphocytic lymphoma, and 2 patients with diffuse histiocytic lymphoma. It was concluded that the Rappaport classification is applicable to orbital lymphoid tumors and that those lymphomas which do present as primary tumors should be staged as one would stage the same histologic category of lymphoma presenting in other sites. Radiation therapy appears to be an effective treatment for local control; however, patients with primary orbital lymphoma should undergo observation for systemic disease similar to patients with lymphoma presenting in other sites. Excisional biopsy is recommended to facilitate precise classification.
AuthorsH H Tewfik, C E Platz, M P Corder, S K Panther, F C Blodi
JournalCancer (Cancer) Vol. 44 Issue 3 Pg. 1022-8 (Sep 1979) ISSN: 0008-543X [Print] United States
PMID383265 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Topics
  • Aged
  • Female
  • Humans
  • Hyperplasia
  • Lymphoid Tissue (pathology)
  • Lymphoma (classification, pathology, radiotherapy)
  • Lymphoma, Large B-Cell, Diffuse (pathology)
  • Lymphoma, Non-Hodgkin (pathology)
  • Male
  • Middle Aged
  • Orbital Neoplasms (classification, pathology, radiotherapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: